GLOBAL BURDEN OF HIP FRACTURES
What We Do
Global Burden of
Hip Fractures
trends in incidence, post-fracture treatment, and mortality
Hip fracture is a public health burden leading to high morbidity and mortality. To inform health initiatives for improving patient outcomes, longitudinal and cross-geographical comparisons of health data can provide insights on aetiology, risk factors, and effectiveness of healthcare practices. Global reports of disease are typically systematic reviews based upon many studies representing a heterogeneity of methods, sample sizes, and study periods; thus making it a challenge to interpret the report variation between countries. Dr. Lung Cheung, Dr. Wing Sing and Professor Wong at the Department of Pharmacology and Pharmacy at The University of Hong Kong are leading a study of hip fractures using a standardized methodology applied to large databases of health records within geographies of Asia, Oceania, North and South America, Western and Northern Europe.
Research Objectives
Annual incidence of Hip fractures
To estimate the annual incidence of hip fractures, and evaluate the trend during 2005 - 2018
Pharmacological Treatment for Fracture Prevention
To investigate the proportion of patients receiving treatment within 12 months following their initial hip fracture
Mortality rate of hip fracture
To examine the mortality rate of patients with hip fractures within 12 months following their initial hip fracture
Get in touch with us.
General Office, L02-56,
2/F, Laboratory Block,
LKS Faculty of Medicine,
The University of Hong Kong,
21 Sassoon Road,
Pokfulam, Hong Kong SAR.